Abstract
IntroductionColorectal cancer is the fourth leading cause of cancer mortality in developed countries. There is evidence supporting a disproportionate loss of skeletal muscle as an independent prognostic factor. The importance of the systemic inflammatory response as a unifying mechanism for specific loss of skeletal muscle mass in patients with cancer is increasingly recognized. The aim of the present study was to delineate the relationship between the systemic inflammatory response, skeletal muscle index (SMI), skeletal muscle density (SMD), and overall survival in patients with colorectal cancer.Materials and methodsThe study included 650 patients with primary operable colorectal cancer. Computed tomography scans were used to define the presence of visceral obesity, sarcopenia (low SMI), and myosteatosis (low SMD). Tumour and patient characteristics were recorded. Survival analysis was carried out using univariate and multivariate Cox regression.ResultsA total of 650 patients (354 men and 296 women) were included. The majority of patients were over 65 years of age (64%) and overweight or obese (68%). On univariate survival analysis, age, ASA, TNM stage, modified Glasgow Prognostic Score (mGPS), body mass index, subcutaneous fat index, visceral obesity, SMI, and SMD were significantly associated with overall survival (all P < 0.05). A low SMI and SMD were significantly associated with an elevated mGPS (<0.05). On multivariate analysis, SMI (Martin) [hazard ratio (HR) 1.50, 95% confidence interval (CI) 1.04–2.18, P = 0.031], SMD (Xiao) (HR 1.42, 95% CI 0.98–2.05, P = 0.061), and mGPS (HR 1.44, 95% CI 1.15–1.79, P = 0.001) were independently associated with overall survival. SMD but not SMI was significantly associated with ASA (P < 0.001).ConclusionsThis study delineates the relationship between the loss of quantity and quality of skeletal muscle mass, the systemic inflammatory response, and survival in patients with operable colorectal cancer.
Highlights
Colorectal cancer is the fourth leading cause of cancer mortality in developed countries
Mortality within 30 days of the index procedure or during the index admission was excluded from subsequent survival analysis
skeletal muscle index (SMI) and skeletal muscle density (SMD) were associated with the presence of a systemic inflammatory and had independent prognostic value
Summary
Colorectal cancer is the fourth leading cause of cancer mortality in developed countries. Weight loss and body mass index (BMI) have been used as an indicator of such nutritional decline and poor prognosis.[2,3] because of the increased number of patients presenting in an overweight or obese state in the developed world, the use of simple weight loss and BMI as a prognostic indicator has been questioned.[4,5,6,7] The ability to use routine computed tomography (CT) scans to measure body composition, in particular skeletal muscle, has resulted in a marked increase in interest in using skeletal muscle index (SMI) and skeletal muscle density (SMD) to predict outcomes in patients with cancer, in CRC.[8]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
